Cannara Biotech, Inc.

  • Market Cap: Small Cap
  • Industry: Other Agricultural Products
  • ISIN: CA13765U2002
CAD
1.72
0.55 (47.01%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

71.56 k

Shareholding (Aug 2025)

FII

0.24%

Held by 1 FIIs

DII

99.76%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

Positive results in May 25

  • OPERATING CASH FLOW(Y) Highest at CAD 16.8 MM
  • ROCE(HY) Highest at 17.21%
  • NET SALES(Q) Highest at CAD 27.33 MM
2

With ROE of -10.12%, it has a very attractive valuation with a 1.58 Price to Book Value

3

Market Beating performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Other Agricultural Products

stock-summary
Market cap

CAD 172 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.27

stock-summary
Return on Equity

-8.19%

stock-summary
Price to Book

1.68

Revenue and Profits:
Net Sales:
27 Million
(Quarterly Results - May 2025)
Net Profit:
4 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
32.31%
0%
32.31%
6 Months
115.0%
0%
115.0%
1 Year
142.25%
0%
142.25%
2 Years
72.0%
0%
72.0%
3 Years
63.81%
0%
63.81%
4 Years
4.24%
0%
4.24%
5 Years
0%
0%
0.0%

Cannara Biotech, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
111.27%
EBIT Growth (5y)
5.71%
EBIT to Interest (avg)
-2.93
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.46
Sales to Capital Employed (avg)
0.59
Tax Ratio
1.39%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.24%
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.58
EV to EBIT
-19.68
EV to EBITDA
-56.04
EV to Capital Employed
1.44
EV to Sales
1.84
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-7.30%
ROE (Latest)
-10.12%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Aug 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.24%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - May'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "May'25",
        "Nov'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "27.30",
          "val2": "25.10",
          "chgp": "8.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.70",
          "val2": "-0.50",
          "chgp": "240.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.10",
          "val2": "1.20",
          "chgp": "-8.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "7.30",
          "val2": "6.30",
          "chgp": "15.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4.10",
          "val2": "2.30",
          "chgp": "78.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-21.00%",
          "val2": "-83.10%",
          "chgp": "6.21%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Aug'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Aug 2024 is 42.58% vs 60.06% in Aug 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Aug 2024 is -7.25% vs 200.00% in Aug 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Aug'24",
        "Aug'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "81.70",
          "val2": "57.30",
          "chgp": "42.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-11.60",
          "val2": "-4.40",
          "chgp": "-163.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.70",
          "val2": "5.30",
          "chgp": "7.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "25.60",
          "val2": "21.20",
          "chgp": "20.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "6.40",
          "val2": "6.90",
          "chgp": "-7.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-219.10%",
          "val2": "-163.90%",
          "chgp": "-5.52%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - May'25 - QoQstock-summary

May'25
Nov'24
Change(%)
Net Sales
27.30
25.10
8.76%
Operating Profit (PBDIT) excl Other Income
0.70
-0.50
240.00%
Interest
1.10
1.20
-8.33%
Exceptional Items
7.30
6.30
15.87%
Consolidate Net Profit
4.10
2.30
78.26%
Operating Profit Margin (Excl OI)
-21.00%
-83.10%
6.21%
USD in Million.
Net Sales

Not Applicable: The company has declared_date for only one period

Consolidated Net Profit

Not Applicable: The company has declared_date for only one period

Annual Results Snapshot (Consolidated) - Aug'24stock-summary

Aug'24
Aug'23
Change(%)
Net Sales
81.70
57.30
42.58%
Operating Profit (PBDIT) excl Other Income
-11.60
-4.40
-163.64%
Interest
5.70
5.30
7.55%
Exceptional Items
25.60
21.20
20.75%
Consolidate Net Profit
6.40
6.90
-7.25%
Operating Profit Margin (Excl OI)
-219.10%
-163.90%
-5.52%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Aug 2024 is 42.58% vs 60.06% in Aug 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Aug 2024 is -7.25% vs 200.00% in Aug 2023

stock-summaryCompany CV
About Cannara Biotech, Inc. stock-summary
stock-summary
Cannara Biotech, Inc.
Other Agricultural Products
Cannara Biotech Inc. is a Canada-based vertically integrated cannabis company. The Company’s segments include indoor cannabis operations and electronic commerce retail. The indoor cannabis segment's operations include cultivation, processing and sale of dried cannabis and cannabis derivatives for the Quebec and Canadian market. The Company also operates as an electronic commerce retailer of United States hemp-based cannabidiol (CBD) products for the United States market. Its subsidiaries include Cannara Biotech (Quebec) Inc. and ShopCBD.com Inc.
Company Coordinates stock-summary
Company Details
Suite 2050 - 1055 West Georgia Street, Royal Centre, P.O. Box 11121, VANCOUVER BC : V6E 3P3
stock-summary
Tel: 1 514 9139136
stock-summary
stock-summary
Registrar Details